We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-14.12%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$64.1B
AUM Growth
-$17.5B
Cap. Flow
-$4.25B
Cap. Flow %
-6.62%
Top 10 Hldgs %
6.66%
Holding
4,541
New
702
Increased
1,343
Reduced
1,571
Closed
844

Top Sells

Rank Stock Value
1
FTV icon
Fortive
FTV
+$1.27B
2
ANDV
Andeavor
ANDV
+$1.11B
3
AET
Aetna Inc
AET
+$535M
4
MSFT icon
Microsoft
MSFT
+$350M
5
AMZN icon
Amazon
AMZN
+$290M

Sector Composition

Rank Sector Weight
1 Healthcare 13.69%
2 Technology 13.64%
3 Financials 12.49%
4 Consumer Discretionary 10.83%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTSI icon
3551
VirTra
VTSI
$33.8M
$78K ﹤0.01%
25,355
-25,884
-51% -$110K
JCP
3552
DELISTED
J.C. Penney Company, Inc.
JCP
$78K ﹤0.01%
75,468
+46,192
+158% +$64.8K
LTS
3553
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$77K ﹤0.01%
32,843
+7,014
+27% +$18.8K
CLDX icon
3554
Celldex Therapeutics
CLDX
$3.19B
$75K ﹤0.01%
25,292
-96,525
-79% -$474K
SQBG
3555
DELISTED
Sequential Brands Group, Inc.
SQBG
$75K ﹤0.01%
2,341
-8,834
-79% -$399K
CTRC
3556
DELISTED
Centric Brands Inc. Common Stock
CTRC
$75K ﹤0.01%
+21,939
New +$104K
ESV
3557
CALL
DELISTED
Ensco Rowan plc
ESV
$75K ﹤0.01%
5,250
-1,750
-25% -$45.1K
DBD
3558
DELISTED
Diebold Nixdorf Incorporated
DBD
$74K ﹤0.01%
29,584
-546,174
-95% -$1.96M
OIBR.C
3559
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$74K ﹤0.01%
+46,150
New +$124K
INTT icon
3560
inTEST
INTT
$145M
$73K ﹤0.01%
11,864
-24,142
-67% -$165K
XXII
3561
22nd Century Group
XXII
$2.63M
0
SRRA
3562
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$73K ﹤0.01%
1,382
-33,968
-96% -$2.17M
NE
3563
CALL
DELISTED
Noble Corporation
NE
$73K ﹤0.01%
28,000
ASLN
3564
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$72K ﹤0.01%
454
-386
-46% -$86.4K
ALTO icon
3565
Alto Ingredients
ALTO
$325M
$69K ﹤0.01%
79,793
-316,010
-80% -$522K
TANH icon
3566
Tantech Holdings
TANH
$5.23M
$69K ﹤0.01%
4
HNRG icon
3567
Hallador Energy
HNRG
$752M
$65K ﹤0.01%
+12,807
New +$74.9K
LXU icon
3568
LSB Industries
LXU
$772M
$65K ﹤0.01%
+15,414
New +$90.5K
SABA
3569
Saba Capital Income & Opportunities Fund II
SABA
$219M
$65K ﹤0.01%
+5,400
New +$66K
JP
3570
DELISTED
Jupai Holdings Limited American depositary shares, each representing six ordinary shares
JP
$64K ﹤0.01%
14,552
-164,217
-92% -$1.19M
RRTS
3571
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$64K ﹤0.01%
5,132
-18,396
-78% -$279K
BKT icon
3572
BlackRock Income Trust
BKT
$336M
$62K ﹤0.01%
+3,670
New +$62.3K
TAC icon
3573
TransAlta
TAC
$3.83B
$62K ﹤0.01%
+14,946
New +$78.3K
LAC
3574
DELISTED
Lithium Americas Corp. Common Shares
LAC
$62K ﹤0.01%
19,605
+5,379
+38% +$20.4K
HIX
3575
Western Asset High Income Fund II
HIX
$350M
$61K ﹤0.01%
+10,600
New +$64.2K

Similar funds

Israel Englander's Q4 2018 Portfolio in Review

As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.

  • Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
  • Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
  • Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
  • Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
  • Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
  • Israel Englander opened 702 new positions and closed 844 in Q4 2018.
  • Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.

Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.